290 related articles for article (PubMed ID: 16543372)
1. knocking down liver ccaat/enhancer-binding protein alpha by adenovirus-transduced silent interfering ribonucleic acid improves hepatic gluconeogenesis and lipid homeostasis in db/db mice.
Qiao L; MacLean PS; You H; Schaack J; Shao J
Endocrinology; 2006 Jun; 147(6):3060-9. PubMed ID: 16543372
[TBL] [Abstract][Full Text] [Related]
2. Metabolic response of mice to a postnatal ablation of CCAAT/enhancer-binding protein alpha.
Yang J; Croniger CM; Lekstrom-Himes J; Zhang P; Fenyus M; Tenen DG; Darlington GJ; Hanson RW
J Biol Chem; 2005 Nov; 280(46):38689-99. PubMed ID: 16166091
[TBL] [Abstract][Full Text] [Related]
3. Increased phosphoenolpyruvate carboxykinase gene expression and steatosis during hepatitis C virus subgenome replication: role of nonstructural component 5A and CCAAT/enhancer-binding protein β.
Qadri I; Choudhury M; Rahman SM; Knotts TA; Janssen RC; Schaack J; Iwahashi M; Puljak L; Simon FR; Kilic G; Fitz JG; Friedman JE
J Biol Chem; 2012 Oct; 287(44):37340-51. PubMed ID: 22955269
[TBL] [Abstract][Full Text] [Related]
4. The transcription factor CCAAT/enhancer-binding protein beta regulates gluconeogenesis and phosphoenolpyruvate carboxykinase (GTP) gene transcription during diabetes.
Arizmendi C; Liu S; Croniger C; Poli V; Friedman JE
J Biol Chem; 1999 May; 274(19):13033-40. PubMed ID: 10224054
[TBL] [Abstract][Full Text] [Related]
5. The SMILE transcriptional corepressor inhibits cAMP response element-binding protein (CREB)-mediated transactivation of gluconeogenic genes.
Lee JM; Han HS; Jung YS; Harris RA; Koo SH; Choi HS
J Biol Chem; 2018 Aug; 293(34):13125-13133. PubMed ID: 29950523
[TBL] [Abstract][Full Text] [Related]
6. Keratinocyte growth factor and the transcription factors C/EBP alpha, C/EBP delta, and SREBP-1c regulate fatty acid synthesis in alveolar type II cells.
Mason RJ; Pan T; Edeen KE; Nielsen LD; Zhang F; Longphre M; Eckart MR; Neben S
J Clin Invest; 2003 Jul; 112(2):244-55. PubMed ID: 12865412
[TBL] [Abstract][Full Text] [Related]
7. Hepatic glucokinase is required for the synergistic action of ChREBP and SREBP-1c on glycolytic and lipogenic gene expression.
Dentin R; Pégorier JP; Benhamed F; Foufelle F; Ferré P; Fauveau V; Magnuson MA; Girard J; Postic C
J Biol Chem; 2004 May; 279(19):20314-26. PubMed ID: 14985368
[TBL] [Abstract][Full Text] [Related]
8. CCAAT/enhancer-binding protein beta deletion reduces adiposity, hepatic steatosis, and diabetes in Lepr(db/db) mice.
Schroeder-Gloeckler JM; Rahman SM; Janssen RC; Qiao L; Shao J; Roper M; Fischer SJ; Lowe E; Orlicky DJ; McManaman JL; Palmer C; Gitomer WL; Huang W; O'Doherty RM; Becker TC; Klemm DJ; Jensen DR; Pulawa LK; Eckel RH; Friedman JE
J Biol Chem; 2007 May; 282(21):15717-29. PubMed ID: 17387171
[TBL] [Abstract][Full Text] [Related]
9. The developmental regulation of peroxisome proliferator-activated receptor-gamma coactivator-1alpha expression in the liver is partially dissociated from the control of gluconeogenesis and lipid catabolism.
Yubero P; Hondares E; Carmona MC; Rossell M; Gonzalez FJ; Iglesias R; Giralt M; Villarroya F
Endocrinology; 2004 Sep; 145(9):4268-77. PubMed ID: 15178647
[TBL] [Abstract][Full Text] [Related]
10. Prolactin regulatory element-binding (PREB) protein regulates hepatic glucose homeostasis.
Park JM; Kim MY; Kim TH; Min DK; Yang GE; Ahn YH
Biochim Biophys Acta Mol Basis Dis; 2018 Jun; 1864(6 Pt A):2097-2107. PubMed ID: 29601978
[TBL] [Abstract][Full Text] [Related]
11. Amelioration of glucose tolerance by hepatic inhibition of nuclear factor kappaB in db/db mice.
Tamura Y; Ogihara T; Uchida T; Ikeda F; Kumashiro N; Nomiyama T; Sato F; Hirose T; Tanaka Y; Mochizuki H; Kawamori R; Watada H
Diabetologia; 2007 Jan; 50(1):131-41. PubMed ID: 17093946
[TBL] [Abstract][Full Text] [Related]
12. Roux-en-Y Gastric Bypass Improves Metabolic Conditions in Association with Increased Serum Bile Acids Level and Hepatic Farnesoid X Receptor Expression in a T2DM Rat Model.
Yan Y; Sha Y; Huang X; Yuan W; Wu F; Hong J; Fang S; Huang B; Hu C; Wang B; Zhang X
Obes Surg; 2019 Sep; 29(9):2912-2922. PubMed ID: 31079286
[TBL] [Abstract][Full Text] [Related]
13. Impaired lipid accumulation by trans10, cis12 CLA during adipocyte differentiation is dependent on timing and length of treatment.
Granlund L; Pedersen JI; Nebb HI
Biochim Biophys Acta; 2005 Feb; 1687(1-3):11-22. PubMed ID: 15708349
[TBL] [Abstract][Full Text] [Related]
14. Gestational high fat diet programs hepatic phosphoenolpyruvate carboxykinase gene expression and histone modification in neonatal offspring rats.
Strakovsky RS; Zhang X; Zhou D; Pan YX
J Physiol; 2011 Jun; 589(Pt 11):2707-17. PubMed ID: 21486814
[TBL] [Abstract][Full Text] [Related]
15. Berberine Attenuates Development of the Hepatic Gluconeogenesis and Lipid Metabolism Disorder in Type 2 Diabetic Mice and in Palmitate-Incubated HepG2 Cells through Suppression of the HNF-4α miR122 Pathway.
Wei S; Zhang M; Yu Y; Lan X; Yao F; Yan X; Chen L; Hatch GM
PLoS One; 2016; 11(3):e0152097. PubMed ID: 27011261
[TBL] [Abstract][Full Text] [Related]
16. CCAAT/enhancer binding protein alpha (C/EBPalpha) in adipose tissue regulates genes in lipid and glucose metabolism and a genetic variation in C/EBPalpha is associated with serum levels of triglycerides.
Olofsson LE; Orho-Melander M; William-Olsson L; Sjöholm K; Sjöström L; Groop L; Carlsson B; Carlsson LM; Olsson B
J Clin Endocrinol Metab; 2008 Dec; 93(12):4880-6. PubMed ID: 18765514
[TBL] [Abstract][Full Text] [Related]
17. Tangshen formula attenuates hepatic steatosis by inhibiting hepatic lipogenesis and augmenting fatty acid oxidation in db/db mice.
Kong Q; Zhang H; Zhao T; Zhang W; Yan M; Dong X; Li P
Int J Mol Med; 2016 Dec; 38(6):1715-1726. PubMed ID: 27840945
[TBL] [Abstract][Full Text] [Related]
18. Hypertriglyceridemia in lecithin-cholesterol acyltransferase-deficient mice is associated with hepatic overproduction of triglycerides, increased lipogenesis, and improved glucose tolerance.
Ng DS; Xie C; Maguire GF; Zhu X; Ugwu F; Lam E; Connelly PW
J Biol Chem; 2004 Feb; 279(9):7636-42. PubMed ID: 14668345
[TBL] [Abstract][Full Text] [Related]
19. Disruption of hepatic C/EBPalpha results in impaired glucose tolerance and age-dependent hepatosteatosis.
Inoue Y; Inoue J; Lambert G; Yim SH; Gonzalez FJ
J Biol Chem; 2004 Oct; 279(43):44740-8. PubMed ID: 15292250
[TBL] [Abstract][Full Text] [Related]
20. Adenovirus-mediated expression of SIK1 improves hepatic glucose and lipid metabolism in type 2 diabetes mellitus rats.
Song D; Yin L; Wang C; Wen X
PLoS One; 2019; 14(6):e0210930. PubMed ID: 31233505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
